User menu

Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies

Bibliographic reference Sonet, Anne ; Graux, Carlos ; Maertens, Johan ; Hartog, Christine-Maria ; Duyster, Justus ; et. al. Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies.50th Annual Meeting of the American- Society-of-Hematology (San Francisco(Ca), Dec 06-09, 2008). In: Blood, Vol. 112, no. 11, p. 1018 (2008)
Permanent URL http://hdl.handle.net/2078.1/59032